GH Research (GHRS) Change in Acquisitions & Divestments (2024 - 2025)

GH Research (GHRS) recorded quarterly Change in Acquisitions & Divestments of $8.9 million in Q4 2025, down 9.81% quarter-over-quarter from $9.8 million in Q3 2025, and up 6.02% on a YoY basis from $8.4 million in Q4 2024.

GH Research (GHRS) Change in Acquisitions & Divestments (2024 - 2025) Analysis & Trends

GH Research's Change in Acquisitions & Divestments history runs 2 years deep, the most recent figure standing at $8.9 million for Q4 2025.

  • In Q4 2025, Change in Acquisitions & Divestments rose 6.02% year-over-year to $8.9 million; the TTM figure through Dec 2025 stood at $26.7 million (down 1.75% YoY), while the FY2025 annual figure was $26.7 million, down 1.75% from the prior year.
  • Change in Acquisitions & Divestments was $8.9 million for Q4 2025 at GH Research, down from $9.8 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $9.8 million in Q3 2025 to a low of $3.2 million in Q2 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn -
7 Psyence Biomedical 241.78 Bn 241.78 Bn -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn
9 Abivax 94.26 Bn 94.26 Bn -
10 GH Research 9.73 Bn 9.63 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 8.86 Mn
Dec 31, 2025 8.86 Mn
Sep 30, 2025 9.82 Mn
Sep 30, 2025 9.82 Mn
Jun 30, 2025 3.18 Mn
Jun 30, 2025 3.18 Mn
Mar 31, 2025 4.84 Mn
Mar 31, 2025 4.84 Mn
Dec 31, 2024 8.36 Mn
Dec 31, 2024 8.36 Mn
Sep 30, 2024 5.29 Mn
Sep 30, 2024 5.29 Mn
Jun 30, 2024 9.74 Mn
Jun 30, 2024 9.74 Mn
Mar 31, 2024 3.80 Mn
Mar 31, 2024 3.80 Mn